title: Duration of postictal psychotic episodes.
abstract: OBJECTIVE
  To clarify duration of postictal psychosis (PIP) episodes and identify factors that influence its duration.
  
  
  METHODS
  Fifty-eight patients with epilepsy exhibited 151 PIP episodes during a mean follow-up period of 12.8 years. Distribution of the duration of these episodes was determined, and factors potentially affecting were analyzed. Factors analyzed included PIP-related variables (i.e., antecedent seizures and the lucid interval) and patient characteristics (i.e., type of epilepsy, lateralization of EEG abnormalities, and intellectual functioning).
  
  
  RESULTS
  The mean duration of the 58 first PIP episodes was 10.5 days, and that of all 151 PIP episodes (including multiple episodes) was 9.2 days. Approximately 95% of the PIP episodes resolved within 1 month. Most PIP-related variables, except for antipsychotic drugs administered, were not associated with duration of the episodes. Several patient characteristics, i.e., history of interictal psychosis, family history of psychosis, and intellectual functioning, were associated with duration of the PIP episodes.
  
  
  CONCLUSIONS
  This study showed that most PIP episodes last less than 1 month. PIP episodes appear to be prolonged when individuals have an underlying vulnerability to psychosis. Clinical phenomena that can trigger PIP may not determine the course of the PIP episode.
authors: Adachi Mental Clinic, Kitano 7-5-12, Kiyota, Sapporo 004-0867, Japan. adacchan@tky2.eweb.ne.jp
authors: Naoto
authors: N
authors: Adachi
authors: Masumi
authors: M
authors: Ito
authors: Kousuke
authors: K
authors: Kanemoto
authors: Nozomi
authors: N
authors: Akanuma
authors: Mitsutoshi
authors: M
authors: Okazaki
authors: Shiro
authors: S
authors: Ishida
authors: Masanori
authors: M
authors: Sekimoto
authors: Masaaki
authors: M
authors: Kato
authors: Jun
authors: J
authors: Kawasaki
authors: Yukari
authors: Y
authors: Tadokoro
authors: Tomonori
authors: T
authors: Oshima
authors: Teiichi
authors: T
authors: Onuma
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000503:physiopathology; D015897:Comorbidity; D004569:Electroencephalography / Q000706:statistics & numerical data; D004827:Epilepsy / Q000150:complications* / Q000503:physiopathology / Q000523:psychology; D005163:Factor Analysis, Statistical; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality; D006801:Humans; D038801:International Classification of Diseases / Q000706:statistics & numerical data; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011594:Psychometrics; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000209:etiology* / Q000523:psychology; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents